329 related articles for article (PubMed ID: 34619443)
1. Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks.
Daniulaityte R; Silverstein SM; Getz K; Juhascik M; McElhinny M; Dudley S
Int J Drug Policy; 2022 Jan; 99():103463. PubMed ID: 34619443
[TBL] [Abstract][Full Text] [Related]
2. Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs.
Daniulaityte R; Ruhter L; Juhascik M; Silverstein S
Harm Reduct J; 2023 Apr; 20(1):54. PubMed ID: 37081499
[TBL] [Abstract][Full Text] [Related]
3. Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.
Daniulaityte R; Carlson RR; Juhascik MP; Strayer KE; Sizemore IE
Int J Drug Policy; 2019 Sep; 71():3-9. PubMed ID: 31146200
[TBL] [Abstract][Full Text] [Related]
4. "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.
Silverstein SM; Daniulaityte R; Martins SS; Miller SC; Carlson RG
Int J Drug Policy; 2019 Dec; 74():76-83. PubMed ID: 31563098
[TBL] [Abstract][Full Text] [Related]
5. "They say it's fentanyl, but they honestly look like Perc 30s": Initiation and use of counterfeit fentanyl pills.
Daniulaityte R; Sweeney K; Ki S; Doebbeling BN; Mendoza N
Harm Reduct J; 2022 May; 19(1):52. PubMed ID: 35614447
[TBL] [Abstract][Full Text] [Related]
6.
Silverstein SM; Daniulaityte R; Getz K; Zule W
Subst Use Misuse; 2021; 56(11):1687-1696. PubMed ID: 34279180
[TBL] [Abstract][Full Text] [Related]
7. Characterizing prescription opioid, heroin, and fentanyl initiation trajectories: A qualitative study.
Perdue T; Carlson R; Daniulaityte R; Silverstein SM; Bluthenthal RN; Valdez A; Cepeda A
Soc Sci Med; 2024 Jan; 340():116441. PubMed ID: 38061222
[TBL] [Abstract][Full Text] [Related]
8. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry.
Fredericksen RJ; Baker R; Sibley A; Estadt AT; Colston D; Mixson LS; Walters S; Bresett J; Levander XA; Leichtling G; Davy-Mendez T; Powell M; Stopka TJ; Pho M; Feinberg J; Ezell J; Zule W; Seal D; Cooper HLF; Whitney BM; Delaney JAC; Crane HM; Tsui JI
Harm Reduct J; 2024 Apr; 21(1):74. PubMed ID: 38561753
[TBL] [Abstract][Full Text] [Related]
9. Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study.
Hughto JMW; Gordon LK; Stopka TJ; Case P; Palacios WR; Tapper A; Green TC
Subst Abus; 2022; 43(1):465-478. PubMed ID: 34228944
[No Abstract] [Full Text] [Related]
10. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose.
Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S
Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153
[No Abstract] [Full Text] [Related]
11. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
[No Abstract] [Full Text] [Related]
12. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
Roxburgh A; Hall WD; Gisev N; Degenhardt L
Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
[TBL] [Abstract][Full Text] [Related]
13. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
14. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon.
LaForge K; Stack E; Shin S; Pope J; Larsen JE; Leichtling G; Leahy JM; Seaman A; Hoover D; Byers M; Barrie C; Chisholm L; Korthuis PT
J Subst Abuse Treat; 2022 Oct; 141():108849. PubMed ID: 35932759
[TBL] [Abstract][Full Text] [Related]
16. Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With Fentanyl.
Allen C; Arredondo C; Dunham R; Fishman M; Lev L; Mace S; Parks J; Rosa D; Shoyinka S; White D; Williams A
Psychiatr Serv; 2023 Oct; 74(10):1059-1062. PubMed ID: 37042103
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
Weitzman ER; Kossowsky J; Blakemore LM; Cox R; Dowling DJ; Levy O; Needles EW; Levy S
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S98-S109. PubMed ID: 35579508
[TBL] [Abstract][Full Text] [Related]
18. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
19. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
Uzwiak BA; Hudgins A; Pizzicato LN
Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
[TBL] [Abstract][Full Text] [Related]
20. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
